Skip to main content

Table 2 Patients and pathological characteristics

From: Diagnosis of micrometastasis in muscle invasive bladder cancer through immunohistochemistry analysis: is there indication for routine evaluation?

Variable N (%)
Follow-up (months) 48 (1–249)
Age (mean) 66 (39 – 87)
Smoking
 No 20 (32.7)
 Yes 41 (67.2)
Hydronephrosis
 No 36 (59.0)
 Yes 25 (41.0)
ASA classification
 1 4 (6.5)
 2 36 (59.0)
 3 21 (34.5)
Histology
 Urothelial carcinoma 58 (95,1)
 CIS 2 (3.1)
 Without Tumor 1(1,6)
pT stage
 T0 3 (4,9)
 Tis 2 (3.2)
 Ta 6 (9.8)
 T1 9 (14.8)
 T2 16 (26.2)
 T3a 8 (13.1)
 T3b 7 (11.5)
 T4 12 (19.7)
Histological grade
 Low 18 (31.0)
 High 40 (69.0)
Pathologic grade
 0 3 (4,9)
 1 6 (9,8)
 2 12 (19,7)
 3 26 (42,6)
 4 14 (26)
Vascular invasiona
 No 44 (84.6)
 Yes 8 (15.4)
Lymphatic invasiona
 No 33 (63.4)
 Yes 19 (36.5)
Perineural invasiona
 No 26 (76.4)
 Yes 8 (23.6)
Disease progression
 No 42 (68.9)
 Yes 19 (31.1)
Cancer Survival
 12 m (82,4)
 24 m (68)
 36 m (61,8)
 48 m (50,9)
 60 m (45,2)
  1. aExcluding missing cases